A Controlled, Randomized, Phase III, Multicenter, Open Label Study of ABI-007(a Cremophor Free, Protein Stabilized, Nanoparticle Paclitaxel) and Taxol in Patients With Metastatic Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 24 Sep 2014
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors American BioScience
- 22 Oct 2010 New trial record
- 12 Jul 2006 Last checked against ClinicalTrials.gov record.